Skip to main content
Log in

Shift in Expression of HLA-G mRNA Spliceforms in Pregnancies Complicated by Preeclampsia

  • Original Articles
  • Published:
The Journal of the Society for Gynecologic Investigation: JSGI Aims and scope Submit manuscript

Abstract

Objective

Despite emerging data on the in vitro modulatory effects of trophoblast-associated human leukocyte antigen G (HLA-G), its in vivo function needs to be determined. Immunohistochemical studies show a decrease in protein expression of trophoblast HLA-G in preeclampsia. Such a decrease in protein might be the consequence of a shift in HLA-G mRNA spliceform patterns. In an exploratory pilot study we determined trophoblast HLA-G mRNA spliceform distribution in preeclampsia.

Methods

Placental samples were collected immediately after cesarean delivery from pregnancies complicated by preeclampsia or the syndrome hemolysis, elevated liver enzymes, and low platelet count (HELLP) and uncomplicated normotensive pregnancies as controls. HLA-G mRNA spliceform distribution was analyzed using a semiquantitative reverse transcriptase polymerase chain reaction procedure.

Results

Analysis of HLA-G spliceform distribution showed a significant increase in frequency of the G5 form encoding for a soluble HLA-G molecule in preeclampsia. This increase in G5 form was not found in pregnancies complicated by HELLP.

Conclusion

The increased frequency in the expression of the HLA-G G5 spliceform may play a role in the pathophysiology of preeclampsia, in particular through a recently suggested effect of this soluble HLA-G molecule on remodeling of the spiral arteries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kilburn BA, Wang J, Duniec-Dmuchkowski ZM, Leach RE, Romero R, Armant DR. Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line. Biol Reprod 2000;62:739–47.

    Article  CAS  PubMed  Google Scholar 

  2. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002;2:656–63.

    Article  CAS  PubMed  Google Scholar 

  3. Le Bouteiller P, Pizzato N, Barakonyi A, Solier C. HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol 2003;59:219–34.

    Article  PubMed  Google Scholar 

  4. Matijevic R, Johnston T. In vivo assessment of failed trophoblastic invasion of the spiral arteries in pre-eclampsia. Br J Obstet Gynaecol 1999;106:78–82.

    Article  CAS  PubMed  Google Scholar 

  5. Goldman-Wohl DS, Ariel I, Greenfield C, et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000;6:88–95.

    Article  CAS  PubMed  Google Scholar 

  6. Hara N, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: Immunohistological demonstration with anti-HLA-G specific antibody “87G” and anti- cytokeratin antibody “CAM5.2.” Am J Reprod Immunol 1996;36:349–58.

    Article  CAS  PubMed  Google Scholar 

  7. Colbern GT, Chiang MH, Main EK. Expression of the nonclas-sic histocompatibility antigen HLA-G by preeclamptic placenta. Am J Obstet Gynecol 1994;170:1244–50.

    Article  CAS  PubMed  Google Scholar 

  8. O’Brien M, Dausset J, Carosella ED, Moreau P. Analysis of the role of HLA-G in preeclampsia. Hum Immunol 2000;61:1126–31.

    Article  PubMed  Google Scholar 

  9. Lim KH, Zhou Y, Janatpour M, et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol 1997;151:1809–18.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. van der Ven K, Skrablin S, Engels G, Krebs D. HLA-G polymorphisms and allele frequencies in Caucasians. Hum Immunol 1998;59:302–12.

    Article  PubMed  Google Scholar 

  11. Le Bouteiller P. HLA-G: On the track of immunological functions. Eur J Immunogenet 1997;24:397–408.

    Article  PubMed  Google Scholar 

  12. Paul P, Cabestre FA, Ibrahim EC, et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000;61:1138–49.

    Article  CAS  PubMed  Google Scholar 

  13. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, De-Mars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990;248:220–3.

    Article  CAS  PubMed  Google Scholar 

  14. Van Wijk IJ, Griffioen S, Tjoa ML, et al. HLA-G expression in trophoblast cells circulating in maternal peripheral blood during early pregnancy. Am J Obstet Gynecol 2001;184:991–7.

    Article  PubMed  Google Scholar 

  15. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001;166:5018–26.

    Article  CAS  PubMed  Google Scholar 

  16. Le Bouteiller P, Legrand-Abravanel F, Solier C. Soluble HLA-G1 at the materno-foetal interface—a review. Placenta 2003;24(Suppl A):S10–S15.

    Article  PubMed  Google Scholar 

  17. Fuzzi B, Rizzo R, Criscuoli L, et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002; 1273201.

    Google Scholar 

  18. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, et al. A genomewide scan for preeclampsia in the Netherlands. Eur J Hum Genet 2001;9:758–64.

    Article  CAS  PubMed  Google Scholar 

  19. Zusterzeel PL, Peters WH, De Bruyn MA, Knapen MF, Merkus HM, Steegers EA. Glutathione S-transferase isoenzymes in de-cidua and placenta of preeclamptic pregnancies. Obstet Gynecol 1999;94:1033–8.

    CAS  PubMed  Google Scholar 

  20. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892–8.

    Article  CAS  PubMed  Google Scholar 

  21. Moreau P, Carosella E, Gluckman E, et al. Alternative transcripts of the MHC of the non-classical class I HLA-G gene in the trophoblast during the first pregnancy trimester and in the placenta at term. C R Acad Sci III 1995;318:837–42.

    CAS  PubMed  Google Scholar 

  22. Onno M, Guillaudeux T, Amiot L, et al. The HLA-G gene is expressed at a low mRNA level in different human cells and tissues. Hum Immunol 1994;41:79–86.

    Article  CAS  PubMed  Google Scholar 

  23. Starzyk KA, Salafia CM, Pezzullo JC, et al. Quantitative differences in arterial morphometry define the placental bed in preeclampsia. Hum Pathol 1997;28:353–8.

    Article  CAS  PubMed  Google Scholar 

  24. Grummer R, Donner A, Winterhager E. Characteristic growth of human choriocarcinoma xenografts in nude mice. Placenta 1999;20:547–53.

    Article  CAS  PubMed  Google Scholar 

  25. Rebmann V, Pfeiffer K, Passier M, et al. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999;53:14–22.

    Article  CAS  PubMed  Google Scholar 

  26. Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000;183:682–8.

    Article  CAS  PubMed  Google Scholar 

  27. Terrone DA, Panehart BK, May WL, Moore A, Magann EF, Martin JNJ. Leukocytosis is proportional to HELLP syndrome severity: Evidence for an inflammatory form of preeclampsia. South Med J 2000;93:768–71.

    Article  CAS  PubMed  Google Scholar 

  28. Lee N, Malacko AR, Ishitani A, et al. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995;3:591–600.

    Article  CAS  PubMed  Google Scholar 

  29. Hiby SE, King A, Sharkey A, Loke YW. Molecular studies of trophoblast HLA-G: Polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens 1999;53:1–13.

    Article  CAS  PubMed  Google Scholar 

  30. Hannke-Lohmann A, Pildner VS, Dehne K, et al. Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia. Obstet Gynecol 2000;96:582–7.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric A. P. Steegers MD, PhD.

Additional information

This study was supported by “Zorg Onderzoek Nederland” (grant no. 2810063).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Emmer, P.M., Joosten, I., Schut, M.H. et al. Shift in Expression of HLA-G mRNA Spliceforms in Pregnancies Complicated by Preeclampsia. Reprod. Sci. 11, 220–226 (2004). https://doi.org/10.1016/j.jsgi.2003.10.011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.jsgi.2003.10.011

Key words

Navigation